Skip to main content
. Author manuscript; available in PMC: 2024 Mar 8.
Published in final edited form as: Pancreas. 2022 Aug 1;51(7):814–820. doi: 10.1097/MPA.0000000000002102

TABLE 4.

Multivariable Analysis of IBD as a Predictor of High-Risk Transformation, Malignant Transformation, and Surgical Intervention Over Time*

High-Risk Transformation
Malignant Transformation
Surgery
OR (95% CI) P OR (95% CI) P OR (95% CI) P

IBD as a predictor 1.03 (0.29–3.60) 0.97 0.81 (0.24–2.75) 0.74 0.47 (0.14–1.58) 0.23
IBD cohort
 Age 0.99 (0.96–1.01) 0.25 0.98 (0.97–1.00) 0.08 0.97 (0.96–0.99) <0.001
 CCI 1.06 (0.96–1.18) 0.25 1.06 (0.97–1.15) 0.17 0.99 (0.91–1.07) 0.71
 White 0.96 (0.42–2.17) 0.92 0.99 (0.51–1.90) 0.97 1.15 (0.64–2.08) 0.64
 Immunosuppressants 1.09 (0.40–2.99) 0.87 0.89 (0.36–2.20) 0.80 0.75 (0.31–1.182) 0.53
*

Multivariable analysis of predictors of aforementioned outcomes in the IBD cohort is also presented.